SNR behavior of coherent phase demodulators. Radio communications study on noise threshold reduction Final report

Signal to noise ratio analysis at outputs of three coherent phase detectors for radio noise threshold reduction stud

Multipath signal model development

The development and use of mathematical models of signals received through the multipath environmental of a TDRS-to-user spacecraft link and vice versa are discussed. The TDRS (tracking and data relay satellite) will be in synchronous orbit. The user spacecraft will be in a low altitude orbit between 200 and 4000 km

Simulation of the TDRS multipath environment

Design principles and implementation methods are discussed for simulating the propagation path between a tracking and data relay satellite and a mission spacecraft. The emphasis is on multipath and Doppler simulation but additive disturbances are also considered. The recommended form of the simulator is fed separately with the unmodulated carrier, the unmodulated subcarriers (or spread-spectrum components) and the data signals. The perturbations are also introduced separately; then successive modulation operations are performed. The simulator is segmented into elements that perform the various functions of direct and specular multipath, diffuse fading, Doppler shift and delay spread. Delay spreads are realized by discrete delays operating on baseband signals. Doppler simulation and ionospheric or diffuse multipath fading are applied to individual paths before or after modulation of the carrier by delayed baseband signals. Block diagrams are presented on how the different elements are combined to create a complete channel simulator

Dose-Reduced Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplantation for Human Immunodeficiency Virus–Associated Lymphoma: AIDS Malignancy Consortium Study 020

AbstractIntensive chemotherapy for human immunodeficiency virus (HIV)-associated non-Hodgkin lymphoma (NHL) and Hodgkin lymphoma (HL) has resulted in durable remissions in a substantial proportion of patients. High-dose chemotherapy and autologous stem cell transplantation (AuSCT), moreover, has resulted in sustained complete remissions in selected patients with recurrent chemosensitive disease. Based on a favorable experience with dose-reduced high-dose busulfan, cyclophosphamide, and AuSCT for older patients with non-HIV–associated aggressive lymphomas, an AIDS Malignancy Consortium multicenter trial was undertaken using the same dose-reduced busulfan and cyclophosphamide preparative regimen with AuSCT for recurrent HIV-associated NHL and HL. Of the 27 patients in the study, 20 received an AuSCT. The median time to achievement of an absolute neutrophil count (ANC) of ≥ 0.5×109/L was 11 days (range, 9-16 days). The median time to achievement of an unsupported platelet count of ≥ 20×109/L was 13 days (range, 6-57 days). One patient died on day +33 posttransplantation from hepatic veno-occlusive disease (VOD) and multiorgan failure. No other fatal regimen-related toxicity occurred. Ten of 19 patients (53%) were in complete remission at the time of their day +100 post-AuSCT evaluation. Of the 20 patients, 10 were alive and event-free at a median of 23 weeks post-AuSCT. Median overall survival (OS) was not reached by 13 of the 20 patients alive at the time of last follow-up. This multi-institutional trial demonstrates that a regimen of dose-reduced high-dose busulfan, cyclophosphamide, and AuSCT is well tolerated and is associated with favorable disease-free survival (DFS) and OS probabilities for selected patients with HIV-associated NHL and HL

Molecular and Clinical Assessment in the Treatment of AIDS Kaposi Sarcoma with Valproic Acid

The AIDS Malignancy Consortium (AMC) undertook a pilot trial of valproic acid (VA) in patients with AIDS-associated Kaposi’s sarcoma (KS). Treatment was associated with low toxicity, but the KS clinical response and KS herpesvirus lytic induction rates were not sufficiently high to meet pre-defined criteria for efficacy

Oxide‐Based Solid‐State Batteries: A Perspective on Composite Cathode Architecture

The garnet-type phase Li$_7$La$_3$Zr$_2$O$_{12}$ (LLZO) attracts significant attention as an oxide solid electrolyte to enable safe and robust solid-state batteries (SSBs) with potentially high energy density. However, while significant progress has been made in demonstrating compatibility with Li metal, integrating LLZO into composite cathodes remains a challenge. The current perspective focuses on the critical issues that need to be addressed to achieve the ultimate goal of an all-solid-state LLZO-based battery that delivers safety, durability, and pack-level performance characteristics that are unobtainable with state-of-the-art Li-ion batteries. This perspective complements existing reviews of solid/solid interfaces with more emphasis on understanding numerous homo- and heteroionic interfaces in a pure oxide-based SSB and the various phenomena that accompany the evolution of the chemical, electrochemical, structural, morphological, and mechanical properties of those interfaces during processing and operation. Finally, the insights gained from a comprehensive literature survey of LLZO–cathode interfaces are used to guide efforts for the development of LLZO-based SSBs